-+ 0.00%
-+ 0.00%
-+ 0.00%

Revive Therapeutics proposes issuing 1,221,516 shares at $0.05 to settle $61,061 debt

PUBT·08/19/2026 18:35:16
Listen to the news
Revive Therapeutics proposes issuing 1,221,516 shares at $0.05 to settle $61,061 debt
  • Revive Therapeutics proposed settling trade payables of $61,061 by issuing up to 1,221,516 common shares.
  • Settlement shares priced at $0.05 each; creditors described as arm’s length.
  • Closing expected no earlier than five business days; subject to Canadian Securities Exchange acceptance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revive Therapeutics Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608191435ACCESSWRNAPR_____1209358) on August 19, 2026, and is solely responsible for the information contained therein.